Literature DB >> 14569469

[Relationship between blood glucose control and psychiatric disorders in type II diabetic patients].

Ibrahim Eren, Ozlem Erdi, Ramazan Ozcankaya.   

Abstract

OBJECTIVE: To explore specific psychiatric comorbidity among type II DM patients with poor and good glycemic control.
METHOD: One hundred four patients with type II DM attending outpatient department of the Endocrinology Unit of Süleyman Demirel University Medical Faculty were included in this study. Patients were divided into two groups according to HbA1c level: >7% defined group 1 with poor glycemic control (n=40), and <7% defined group 2 with good glycemic control (n=64). All patients were assessed using a semi structured sociodemographic data form, the Structured Clinical Interview for DSM-IV-Clinical Version (SCID-I/CV), Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS) and the Minimental State Examination Scale.
RESULTS: The prevalence rate of psychiatric disorders were as follows: major depressive disorder 67.5%, dysthymic disorder 10.0%, generalized anxiety disorder 7.5%, obsessive compulsive disorder 5%, social phobia 2.5% and nicotine dependence 5% in group 1 patients; and major depressive disorder 43.8%, dysthymic disorder 10.9%, paranoid disorder 3.1%, obsessive compulsive disorder 6.3%, social phobia 4.7%, generalized anxiety disorder 6.3%, nicotine dependence 9.4% and alcohol dependence 3.1% in group 2 patients. Major depressive disorder frequency was significantly higher in group1 patients than group 2 patients. HDRS and HARS scores were significantly higher in group 1 patients than in group 2 patients. Significant positive correlations were found between HDRS, HARS scores, number of depressive episodes and the level of HbA1c in the diabetic patients.
CONCLUSION: Major depressive disorder was more frequent in diabetic patients with poor glycemic control than in those with good glycemic control. There was a strong association between level of HbA1c and depression and anxiety symptom level.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14569469

Source DB:  PubMed          Journal:  Turk Psikiyatri Derg        ISSN: 1300-2163


  8 in total

1.  Sweetened blood cools hot tempers: physiological self-control and aggression.

Authors:  C Nathan DeWall; Timothy Deckman; Matthew T Gailliot; Brad J Bushman
Journal:  Aggress Behav       Date:  2011 Jan-Feb       Impact factor: 2.917

Review 2.  The role of mental disorders in precision medicine for diabetes: a narrative review.

Authors:  Sanne H M Kremers; Sarah H Wild; Petra J M Elders; Joline W J Beulens; David J T Campbell; Frans Pouwer; Nanna Lindekilde; Maartje de Wit; Cathy Lloyd; Femke Rutters
Journal:  Diabetologia       Date:  2022-06-22       Impact factor: 10.460

3.  Depression in Barbadian adults with type 2 diabetes.

Authors:  Allison A DaSantos; Carlisle Goddard; Dalip Ragoobirsingh
Journal:  J Diabetes Metab Disord       Date:  2020-11-20

4.  Depression, glycemic control and type 2 diabetes.

Authors:  Marcelo Papelbaum; Rodrigo O Moreira; Walmir Coutinho; Rosane Kupfer; Leão Zagury; Silvia Freitas; José C Appolinário
Journal:  Diabetol Metab Syndr       Date:  2011-10-07       Impact factor: 3.320

5.  Evaluation of anxiety condition among type 1 and type 2 diabetic patients.

Authors:  Aliye Bulut; Aziz Bulut
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-11       Impact factor: 2.570

6.  Prevalence of depression in consecutive patients with type 2 diabetes mellitus of 5-year duration and its impact on glycemic control.

Authors:  Cynthia Susan Mathew; Mini Dominic; Rajesh Isaac; Jubbin J Jacob
Journal:  Indian J Endocrinol Metab       Date:  2012-09

7.  The effectiveness of stress management training on blood glucose control in patients with type 2 diabetes.

Authors:  Fereshteh Zamani-Alavijeh; Marzieh Araban; Hamid Reza Koohestani; Mahmood Karimy
Journal:  Diabetol Metab Syndr       Date:  2018-05-08       Impact factor: 3.320

8.  Effect of motivational interviewing intervention on HgbA1C and depression in people with type 2 diabetes mellitus (systematic review and meta-analysis).

Authors:  Kalayou Kidanu Berhe; Haftu Berhe Gebru; Hailemariam Berhe Kahsay
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.